Literature DB >> 23904861

Important issues at heart: cardiovascular risk management in rheumatoid arthritis.

Camille Roubille1, Boulos Haraoui.   

Abstract

Entities:  

Year:  2013        PMID： 23904861      PMCID： PMC3728983          DOI： 10.1177/1759720X13491853

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN： 1759-720X            Impact factor:   5.346


× No keyword cloud information.
  20 in total

1.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

Review 2.  Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Sarah L Westlake; Alexandra N Colebatch; Janis Baird; Nick Curzen; Patrick Kiely; Mark Quinn; Ernest Choy; Andrew J K Ostor; Christopher J Edwards
Journal:  Rheumatology (Oxford)       Date:  2010-11-11       Impact factor: 7.580

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

4.  Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

Authors:  Daniel H Solomon; Elizabeth W Karlson; Eric B Rimm; Carolyn C Cannuscio; Lisa A Mandl; JoAnn E Manson; Meir J Stampfer; Gary C Curhan
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

5.  Patients' knowledge of risk and protective factors for cardiovascular disease.

Authors:  Siddharth A Wartak; Jennifer Friderici; Amir Lotfi; Ashish Verma; Reva Kleppel; Deborah Naglieri-Prescod; Michael B Rothberg
Journal:  Am J Cardiol       Date:  2011-03-15       Impact factor: 2.778

6.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

7.  The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.

Authors:  Paulo J Nicola; Hilal Maradit-Kremers; Véronique L Roger; Steven J Jacobsen; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-02

Review 8.  The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Sarah L Westlake; Alexandra N Colebatch; Janis Baird; Patrick Kiely; Mark Quinn; Ernest Choy; Andrew J K Ostor; Christopher J Edwards
Journal:  Rheumatology (Oxford)       Date:  2009-11-27       Impact factor: 7.580

9.  Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.

Authors:  Mary Chester M Wasko; Abhijit Dasgupta; Helen Hubert; James F Fries; Michael M Ward
Journal:  Arthritis Rheum       Date:  2013-02

10.  Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.

Authors:  Kaisa M Mäki-Petäjä; Maysoon Elkhawad; Joseph Cheriyan; Francis R Joshi; Andrew J K Ostör; Frances C Hall; James H F Rudd; Ian B Wilkinson
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690
View more
  2 in total

Review 1.  The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

Authors:  Camille Roubille; Vincent Richer; Tara Starnino; Collette McCourt; Alexandra McFarlane; Patrick Fleming; Stephanie Siu; John Kraft; Charles Lynde; Janet Pope; Wayne Gulliver; Stephanie Keeling; Jan Dutz; Louis Bessette; Robert Bissonnette; Boulos Haraoui
Journal:  Ann Rheum Dis       Date:  2015-01-05       Impact factor: 19.103

2.  Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study.

Authors:  Yen-Ju Chen; Shih-Chia Liu; Kuo-Lung Lai; Kuo-Tung Tang; Ching-Heng Lin; Yi-Ming Chen; Chih-Wei Tseng; Yu-Mei Chang; Donald F Gotcher; Chuang-Chun Chiou; Shao-Jen Weng; Hsin-Hua Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-08-26       Impact factor: 5.346
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.